多参数磁共振特征在表型和转录组水平识别侵袭性前列腺癌
该回顾性研究纳入206例2013至2017年行根治性前列腺切除术且病灶对应区域有RNA表达数据的患者,分析PIRADS评分与不良病理特征及转录组的关联。结果显示PIRADS评分与不良病理、转移风险及差异基因组通路激活相关。
要点
- PIRADS评分与不良病理风险独立相关(参照PIRADS 3,OR 8.1)。
- PIRADS 4与5间不良病理风险差异未达显著(OR 1.9,P=0.12)。
- PIRADS 5较4更激活PI3K-AKT-mTOR、WNT-β和E2F通路。
核心结论
- PIRADS评分与不良病理结果、转移风险增加及差异基因组通路激活相关。
研究设计与样本
- 回顾性分析206例2013至2017年行根治性前列腺切除术且病灶对应区域有RNA表达数据的患者。
主要发现
- 病灶大小(p=0.03)、PIRADS评分(p=0.02)和包膜外侵犯(p=0.01)与Decipher评分显著相关。
- 多因素分析示PIRADS评分(参照PIRADS 3,OR 8.1,95%CI 1.2-57.5,p=0.04)为不良病理危险因素。
- Gleason分级分组(参照3,OR 5.6,95%CI 1.5-21.1,p=0.01)和前列腺特异性抗原(OR 1.103,95%CI 1.011-1.203)亦为不良病理危险因素。
- PIRADS 4与5间不良病理差异未达显著(OR 1.9,95%CI 0.8-4.5,p=0.12)。
- PI3K-AKT-mTOR、WNT-β和E2F信号通路在PIRADS 5中较PIRADS 4更活跃。
临床怎么用
- 可将PIRADS评分纳入前列腺癌术前风险评估,辅助识别不良病理高危患者。
- PIRADS 5提示特定致癌通路激活,可能为预后分层提供分子层面参考。
局限性
- 回顾性设计,样本量206例,仅纳入行根治术且有RNA数据的患者,存在选择偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Multiparametric magnetic resonance imaging is a diagnostic tool for prostate cancer with limited data on prognostic use. We sought to determine whether multiparametric magnetic resonance could predict aggressive prostate cancer features. MATERIALS AND METHODS: We retrospectively analyzed the records of 206 patients who underwent radical prostatectomy between 2013 and 2017. All patients had available RNA expression data on the final pathology specimen obtained from a location corresponding to a lesion location on multiparametric magnetic resonance imaging. The association between the PIRADS™ (Prostate Imaging Reporting and Data System) score and adverse pathology features were analyzed. We also performed differential transcriptomic analysis between the PIRADS groups. Factors associated with adverse pathology were analyzed using a multivariable logistic regression model. RESULTS: Lesion size (p = 0.03), PIRADS score (p = 0.02) and extraprostatic extension (p = 0.01) associated significantly with the Decipher® score. Multivariable analysis showed that the PIRADS score (referent PIRADS 3, OR 8.1, 95% CI 1.2-57.5, p = 0.04), the Gleason Grade Group (referent 3, OR 5.6, 95% CI 1.5-21.1, p = 0.01) and prostate specific antigen (OR 1.103, 95% CI 1.011-1.203) were risk factors for adverse pathology findings. The difference between PIRADS 4 and 5 did not reach significance (OR 1.9, 95% CI 0.8-4.5, p = 0.12). However, the PI3K-AKT-mTOR, WNT-β and E2F signaling pathways were more active in PIRADS 5 than in PIRADS 4 cases. CONCLUSIONS: The PIRADS score is associated with adverse pathology results, increased metastatic risk and differential genomic pathway activation.
引用
- Beksac AT, Cumarasamy S, Falagario U, et al. Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level. J Urol. 2018. PMID: 30563651. doi:10.1016/j.juro.2018.06.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。